Antioxidants increase number of progenitor endothelial cells through multiple gene expression pathways

References

• Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964–967
   PubMed Web of Science ®Google Scholar
• Crosby JR, Kaminski WE, Schatteman G, Martin PJ, Raines EW, Seifert RA, Bowen-Pope DF. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 2000; 87: 728–730
   PubMed Web of Science ®Google Scholar
• Fadini GP, Sartore S, Albiero M, Baesso I, Murphy E, Menegolo M, Grego F, Vigili de Kreutzenberg S, Tiengo A, Agostini C, Avogaro A. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 2006; 26: 2140–2146
   PubMed Web of Science ®Google Scholar
• Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434–438
   PubMed Web of Science ®Google Scholar
• Takamiya M, Okigaki M, Jin D, Takai S, Nozawa Y, Adachi Y, Urao N, Tateishi K, Nomura T, Zen K, Ashihara E, Miyazaki M, Tatsumi T, Takahashi T, Matsubara H. Granulocyte colony-stimulating factor-mobilized circulating c-Kit + /Flk-1+ progenitor cells regenerate endothelium and inhibit neointimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol 2006; 26: 751–757
   Google Scholar
• Werner N, Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy?. Arterioscler Thromb Vasc Biol 2006; 26: 257–266
   PubMed Web of Science ®Google Scholar
• Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B, Rabelink TJ, van Zonneveld AJ. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004; 53: 195–199
   PubMed Web of Science ®Google Scholar
• Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002; 106: 2781–2786
   PubMed Web of Science ®Google Scholar
• Liguori A, Fiorito C, Balestrieri ML, Crimi E, Bruzzese G, Williams-Ignarro S, D'Amora M, Sommese L, Grimaldi V, Minucci PB, Giovane A, Farzati B, Ignarro LJ, Napoli C. Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease. Eur J Haematol 2007; 80: 258–264
   Google Scholar
• Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, Menegolo M, de Kreutzenberg SV, Tiengo A, Agostini C, Avogaro A. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005; 45: 1449–1457
   PubMed Web of Science ®Google Scholar
• Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 2004; 15: 1983–1992
   PubMed Web of Science ®Google Scholar
• Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, Dimmeler S, Zeiher AM. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111: 2981–2987
   PubMed Web of Science ®Google Scholar
• Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999–1007
   PubMed Web of Science ®Google Scholar
• Rosenzweig A. Circulating endothelial progenitors cells as biomarkers. N Engl J Med 2005; 353: 1055–1057
   Google Scholar
• Ignarro LJ, Balestrieri ML, Napoli C. Nutrition, physical activity, and cardiovascular disease: an update. Cardiovasc Res 2007; 73: 326–340
   PubMed Web of Science ®Google Scholar
• Napoli C, Balestrieri A, Ignarro LJ. Therapeutic approaches in vascular repair induced by adult bone marrow cells and circulating progenitor endothelial cells. Curr Pharm Des 2007; 13: 3245–3251
   PubMed Web of Science ®Google Scholar
• Kawamoto A, Asahara T. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies. Catheter Cardiovasc Interv 2007; 70: 477–484
   PubMed Web of Science ®Google Scholar
• Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997; 272: 20963–20966
   PubMed Web of Science ®Google Scholar
• Napoli C, Williams-Ignarro S, De Nigris F, Lerman LO, Rossi L, Guarino C, Mansueto G, Di Tuoro F, Pignalosa O, De Rosa G, Sica V, Ignarro LJ. Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice. Proc Natl Acad Sci USA 2004; 101: 8797–8802
   PubMed Web of Science ®Google Scholar
• Napoli C, Williams-Ignarro S, de Nigris F, Lerman LO, D'Armiento FP, Crimi E, Byrns RE, Casamassimi A, Lanza A, Gombos F, Sica V, Ignarro LJ. Physical training and metabolic supplementation reduce spontaneous atherosclerotic plaque rupture and prolong survival in hypercholesterolemic mice. Proc Natl Acad Sci USA 2006; 103: 10479–10484
   PubMedGoogle Scholar
• Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary disease. Circulation 2000; 101: 1899–1906
   PubMed Web of Science ®Google Scholar
• Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109: 1127–1132
   PubMedGoogle Scholar
• Clapp BR, Hingorani AD, Kharbanda RK, Mohamed-Ali V, Stephens JW, Vallance P, MacAllister RJ. Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress. Cardiovasc Res 2004; 64: 172–178
   PubMed Web of Science ®Google Scholar
• Casamassimi A, Balestrieri ML, Fiorito C, Schiano C, Maione C, Rossiello R, Grimaldi V, Del Giudice V, Balestrieri C, Farzati B, Sica V, Napoli C. Comparison between total endothelial progenitor cell isolation versus enriched cd133+ culture. J Biochem 2007; 141: 503–511
   PubMed Web of Science ®Google Scholar
• de Nigris F, Lerman LO, Ignarro SW, Sica G, Lerman A, Palinski W, Ignarro LJ, Napoli C. Beneficial effects of antioxidants and L-arginine on oxidation-sensitive gene expression and endothelial NO synthase activity at sites of disturbed shear stress. Proc Natl Acad Sci USA 2003; 100: 1420–1425
   PubMed Web of Science ®Google Scholar
• Napoli C, de Nigris F, Sica V. New advances in microarrays: finding the genes causally involved in disease. Methods Mol Med 2005; 108: 215–233
   PubMedGoogle Scholar
• Napoli C, de Nigris F, Welch JS, Calara FB, Stuart RO, Glass CK, Palinski W. Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray. Circulation 2002; 105: 1360–1367
   PubMed Web of Science ®Google Scholar
• Dennis G, Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003; 4: P3
   PubMed Web of Science ®Google Scholar
• Fiorito C, Balestrieri ML, Crimi E, Giovane A, Grimaldi V, Minucci PB, Servillo L, D'Armiento FP, Farzati B, Napoli C. Effect of L-Arginine on circulating endothelial progenitor cells after moderate physical training in mice. Int J Cardiol 2008; 126: 421–423
   Google Scholar
• Balestrieri ML, Fiorito C, Crimi E, Felice F, Schiano C, Milone L, Casamassimi A, Giovane A, Grimaldi V, del Giudice V, Minucci PB, Mancini FP, Servillo L, D'Armiento FP, Farzati B, Napoli C. Effect of red wine antioxidants and minor polyphenolic constituents on endothelial progenitor cells after physical training in mice. Int J Cardiol 2008; 126: 295–297
   Web of Science ®Google Scholar
• Balestrieri ML, Schiano C, Felice F, Casamassimi A, Balestrieri A, Milone L, Servillo L, Napoli C. Effect of low doses of red wine and pure resveratrol on circulating endothelial progenitor cells. J Biochem 2008; 143: 179–186
   PubMed Web of Science ®Google Scholar
• Paul JD, Powell TM, Thompson M, Benjamin M, Rodrigo M, Carlow A, Annavajjhala V, Shiva S, Dejam A, Gladwin MT, McCoy JP, Zalos G, Press B, Murphy M, Hill JM, Csako G, Waclawiw MA. Cannon RO 3rd. Endothelial progenitor cell mobilization and increased intravascular nitric oxide in patients undergoing cardiac rehabilitation. J Cardiopulm Rehabil Prev 2007; 27: 65–73
   Google Scholar
• de Nigris F, Balestrieri ML, Ignarro S-W, D'Armiento FP, Lerman LO, Byrns R, Crimi E, Palagiano A, Sica V, Ignarro LJ, Napoli C. Therapeutic effects of autologous bone marrow cells and metabolic intervention in the ischemic hindlimb of spontaneously hypertensive rats involve reduced cell senescence and CXCR4/Akt/eNOS pathways. J Cardiov Pharmacol 2007; 50: 424–433
   PubMedGoogle Scholar
• Napoli C, Maione C, Schiano C, Fiorito C, Ignarro LJ. Bone marrow cell-mediated cardiovascular repair: potential of combined therapies. Trends Mol Med 2007; 13: 278–286
   PubMed Web of Science ®Google Scholar
• Li Y, Schellhorn HE. New developments and novel therapeutic perspectives for vitamin C. J Nutr 2007; 137: 2171–2184
   PubMed Web of Science ®Google Scholar
• Seeger FH, Haendeler J, Walter DH, Rochwalsky U, Reinhold J, Urbich C, Rössig L, Corbaz A, Chvatchko Y, Zeiher AM, Dimmeler S. p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 2005; 111: 1184–1191
   PubMed Web of Science ®Google Scholar
• Kieć-Wilk B, Polus A, Grzybowska J, Mikołajczyk M, Hartwich J, Pryjma J, Skrzeczyńska J, Dembinska-Kieć A. Beta-Carotene stimulates chemotaxis of human endothelial progenitor cells. Clin Chem Lab Med 2005; 43: 488–498
   PubMedGoogle Scholar
• Shunsuke O, Kazuhiko A, Hiroki S, Hiromi S, Teruhiko Y, Shumpei O. Gene expression profiles of endothelial progenitor cells by oligonucleotide microarray analysis. Mol Cell Biochem 2007; 298: 125–138
   Google Scholar
• Vales A, Kondo R, Aichberger KJ, Mayerhofer M, Kainz B, Sperr WR, Sillaber C, Jager U, Valent P. Myeloid leukemias express a broad spectrum of VEGF receptors including neuropilin-1 (NRP-1) and NRP-2. Leuk Lymphoma 2007; 48: 1997–2007
   PubMed Web of Science ®Google Scholar
• Jun S, Zhao J, Martin A, Schwartz J, Wang YJ, Wiedmer T, Sims PJ. c-Abl tyrosine kinase binds and phosphorylates phospholipid scramblase 1. Biol Chem 2001; 276: 28984–28990
   Google Scholar
• Sims PJ, Wiedmer T. Unraveling the mysteries of phospholipid scrambling. Thromb Haemost 2001; 86: 266–275
   PubMed Web of Science ®Google Scholar
• Meera N, Jun S, Zhao J, Zhou Q, Sims PJ, Wiedmer T. Plasma membrane phospholipid scramblase 1 promotes EGF-dependent activation of c-Src through the epidermal growth factor receptor. J Biol Chem 2003; 278: 37413–37418
   Google Scholar
• Ejeskär K, Krona C, Carén H, Zaibak F, Li L, Martinsson T, Ioannou PA. Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death. BMC Cancer 2005; 16: 5–161
   Google Scholar
• Lopez-Alemany R, Suelves M, Diaz-Ramos A, Vidal B, Munoz-Canoves P. Alpha-enolase plasminogen receptor in myogenesis. Front Biosci 2005; 10: 30–36
   Web of Science ®Google Scholar
• Davignon J, Cohn JS, Mabile L, Bernier L. Apolipoprotein E and atherosclerosis: insight from animal and human studies. Clin Chim Acta 1999; 286: 115–143
   PubMed Web of Science ®Google Scholar
• Diz-Kucukkaya R, Inanc M, Afshar-Kharghan V, Zhang QE, Lopez JA, Pekcelen Y. P-selectin glycoprotein ligand-1 VNTR polymorphisms and risk of thrombosis in the antiphospholipid syndrome. Ann Rheum Dis 2007; 66: 1378–1380
   PubMed Web of Science ®Google Scholar